What is the recommended diabetic ketoacidosis (DKA) treatment protocol for an adult with arterial pH 6.85, PaCO₂ 12 mm Hg, and serum bicarbonate 5 mmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DKA Treatment Protocol for Severe Acidemia (pH 6.85)

For a patient with pH 6.85, bicarbonate 5 mmol/L, and CO₂ 12 mmHg, you should administer 100 mmol sodium bicarbonate in 400 mL sterile water at 200 mL/h, along with aggressive fluid resuscitation and continuous intravenous insulin infusion. This represents severe DKA with life-threatening acidemia requiring immediate intervention.

Critical Initial Management

1. Bicarbonate Therapy (pH <6.9)

With a pH of 6.85, this patient falls below the 6.9 threshold where bicarbonate therapy is recommended by multiple ADA guidelines 1, 2, 3, 1. The specific protocol is:

  • 100 mmol sodium bicarbonate diluted in 400 mL sterile water
  • Infuse at 200 mL/h 1
  • Reassess pH after infusion completes
  • If pH remains <6.9 after initial treatment, repeat the dose 1

Important caveat: While guidelines recommend bicarbonate for pH <6.9 (Grade B-C evidence), recent systematic reviews show no improvement in time to acidosis resolution, hospital length of stay, or mortality 4, 5, 6, 7. However, the evidence base lacks studies in patients with pH <6.85, making guideline adherence prudent for this extreme acidemia 6.

2. Fluid Resuscitation (Priority #1)

Start immediately before or concurrent with insulin:

  • Isotonic saline (0.9% NaCl) or balanced crystalloid solution
  • Initial rate: 15-20 mL/kg/h for the first 1-2 hours (approximately 1-1.5 L for average adult)
  • Reassess hemodynamic status and adjust accordingly
  • Target: smooth rehydration at 1.5 times maintenance requirements 1, 2, 3

3. Insulin Therapy

Do NOT start insulin until potassium is checked and corrected if needed (see below).

Once potassium ≥3.3 mEq/L:

  • Initial bolus: 0.1 units/kg IV (optional but commonly used in adults)
  • Continuous IV infusion: 0.1 units/kg/h (typically 5-7 units/h for adults) 2, 8
  • Target glucose decline: 50-75 mg/dL per hour 2
  • If glucose doesn't fall by 50 mg/dL in first hour, check hydration status; if adequate, double insulin infusion rate hourly until steady decline achieved 2

4. Potassium Management (Critical)

Check potassium IMMEDIATELY - this is life-threatening:

  • If K⁺ <3.3 mEq/L: HOLD insulin, give potassium replacement first to avoid cardiac arrhythmias or arrest 1
  • If K⁺ 3.3-5.5 mEq/L: Add 20-30 mEq potassium per liter of IV fluid (2/3 KCl, 1/3 KPO₄) 1
  • If K⁺ >5.5 mEq/L: Hold potassium initially, but monitor closely as it will drop rapidly with insulin therapy 1

Warning: Hypokalaemia occurs in ~50% of DKA patients during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality 9. Monitor potassium every 2-4 hours.

Monitoring Protocol

Laboratory Monitoring Every 2-4 Hours:

  • Venous pH (preferred over arterial - easier to obtain, only 0.03 units lower) 2, 3, 2
  • Blood glucose
  • Electrolytes (especially potassium)
  • Anion gap
  • Blood urea nitrogen, creatinine
  • Serum osmolality

When to Transition Glucose Management:

Once glucose reaches 200-250 mg/dL:

  • Add dextrose to IV fluids (D5W or D5 0.45% NaCl)
  • Continue insulin infusion to clear ketones - don't stop insulin just because glucose normalizes
  • Adjust insulin rate to maintain glucose 150-200 mg/dL while acidosis resolves

Resolution Criteria

DKA is resolved when ALL of the following are met 2, 3, 2:

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L 1

Common Pitfalls to Avoid

  1. Starting insulin before checking/correcting potassium - can cause fatal arrhythmias
  2. Stopping IV insulin when glucose normalizes - ketoacidosis takes longer to clear than hyperglycemia; continue insulin until bicarbonate ≥18 and pH >7.3
  3. Abrupt discontinuation of IV insulin - causes rebound hyperglycemia and ketoacidosis; overlap with subcutaneous insulin for 1-2 hours before stopping IV 3
  4. Over-aggressive fluid resuscitation - increases cerebral edema risk, especially in pediatrics; don't exceed 2x maintenance requirements 1
  5. Using bicarbonate as IV bolus - always dilute in sterile water and infuse over time 1
  6. Monitoring only serum/urine ketones by nitroprusside method - this misses β-hydroxybutyrate (the predominant ketone) and can falsely suggest worsening ketosis during treatment 2, 3, 2

Special Considerations for pH 6.85

This represents extreme acidemia with very limited evidence. No randomized trials have studied patients with pH <6.85 6. The bicarbonate recommendation is extrapolated from studies in less severe acidemia (pH 6.9-7.14) where bicarbonate showed no benefit 7. However, at pH 6.85, the theoretical risks of severe acidemia (cardiac dysfunction, impaired oxygen delivery, respiratory muscle weakness) may outweigh the potential harms of bicarbonate therapy (paradoxical CNS acidosis, delayed ketone clearance, hypokalemia) 4, 6.

Monitor closely for:

  • Cardiac arrhythmias
  • Altered mental status/cerebral edema
  • Respiratory depression
  • Need for additional potassium supplementation (bicarbonate drives K⁺ intracellularly) 2

Related Questions

Can sodium bicarbonate be given in severe diabetic ketoacidosis (DKA) to buy time?
What are the indications for administering bicarbonate in diabetic ketoacidosis?
In diabetic ketoacidosis, does blowing off CO₂ via hyperventilation enable the bicarbonate buffer system to remove the excess H⁺ generated by ketone production?
Can D5W (5% dextrose water) be administered with sodium bicarbonate as an IV drip for a patient with diabetic ketoacidosis?
How should I treat a patient with diabetic ketoacidosis (DKA) who has a serum bicarbonate of 8 mmol/L, blood glucose of 618 mg/dL, serum potassium of 4.4 mEq/L, and serum phosphate of 1.7 mg/dL?
Does rifaximin reduce intestinal ammonia production?
In a 25-year-old male taking lithium and phenelzine (an irreversible MAOI), could phenelzine (or the combination of his medications) cause severe orthostatic hypotension and small‑fiber neuropathy that mimic seronegative autoimmune autonomic ganglionopathy?
In a 25‑year‑old man with severe orthostatic hypotension and small‑fiber neuropathy who is taking phenelzine (irreversible monoamine oxidase inhibitor) and chronic lithium therapy, what is the most likely cause of his condition and what are the recommended next steps in management?
In a patient receiving phenelzine (an irreversible MAOI) along with lithium, tirzepatide, and other agents, who developed severe orthostatic hypotension, low supine plasma norepinephrine, selective adrenergic failure, and small‑fiber neuropathy, could phenelzine be the cause and mimic seronegative autoimmune autonomic ganglionopathy, and what tests or clinical features can distinguish a drug‑induced effect from true autoimmune autonomic ganglionopathy?
In a patient with a necrotic toe, a white blood cell count of 28 × 10⁹/L, and a lactate level of 3.1 mmol/L, but stable vital signs, should a 30 mL/kg isotonic crystalloid fluid bolus be administered for sepsis?
What medication should be given to a patient with Parkinson's disease for anxiety or agitation instead of haloperidol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.